This protocol is judged by an institutional critique board, an independent group that reviews any medical trials involving individuals. If a review consists of a Agenda I drug, once the board approves the protocol as moral, the researchers must apply for an investigational new drug (IND) variety through the FDA.Medicine can also comprise unknown s